Antibodies better than chemo with stem cell transplant

09/3/2009 | Yahoo!

Treatment with monoclonal antibodies instead of high-dose chemotherapy might help children with primary immunodeficiencies get the most from stem cell transplants, British researchers reported. Monoclonal antibodies target only the immune cells that cause rejection and not other body tissue, allowing patients to recover more quickly and avoid the toxicity from chemotherapy, the study found.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ